A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.

Key facts

Study ID

NCT02348476

Run by

Allergan

People needed

150

Starts

2014-11-01

Expected to finish

2015-04-01

Last updated by the study team

2015-09-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants treated with Simbrinza™ for Intra-Ocular Pressure (IOP) lowering in at least one eye
• Participants who had at least one-follow-up visit with tolerablity and efficacy data after Simbrinza™ treatment initiation.

You may not qualify if…

• Active ocular disease other than glaucoma or ocular hypertension
• History of any intraocular surgery or glaucoma laser surgery within 3 months.

Where it is running

• Study site — Wheaton, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.